Evanson Asset Management’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Evanson Asset Management’s Portfolio CVRS Stock Details CVRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20,000	Closed	-$17K	–	245
2018 Q4	$17K	Hold	20,000	–	–	﹤0.01%	226
2018 Q3	$28K	Hold	20,000	–	–	0.01%	236
2018 Q2	$17K	Hold	20,000	–	–	﹤0.01%	252
2018 Q1	$27K	Hold	20,000	–	–	0.01%	252
2017 Q4	$20K	Buy	20,000 +10,000	+100%	+$11.3K	﹤0.01%	248
2017 Q3	$15K	Hold	10,000	–	–	﹤0.01%	234
2017 Q2	$19K	Hold	10,000	–	–	﹤0.01%	224
2017 Q1	$13K	Buy	+10,000	New	+$8.14K	﹤0.01%	223

Other funds holding CVRS

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Evanson Asset Management's CVRS Position: Q1 2019 in Review

Evanson Asset Management sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q1 2019, closing a stake of 20,000 shares — an estimated $17K sold.

Evanson Asset Management first reported a position in CVRS in Q1 2017 and held it in 8 quarters. The position peaked at $28K in Q3 2018. 64 funds tracked by Wall St. Rank hold CVRS as of Q1 2019.

Evanson Asset Management reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q1 2019 after selling out during the quarter.
Evanson Asset Management sold 20,000 CORINDUS VASCULAR ROBOTICS, INC shares in Q1 2019, an estimated $17K.
Evanson Asset Management first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q1 2017 and held it in 8 quarters.
Evanson Asset Management's CORINDUS VASCULAR ROBOTICS, INC position peaked at $28K in Q3 2018.
64 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q1 2019.

Based on Evanson Asset Management's 13F filing for Q1 2019, filed 9 Apr 2019.